HIGHBRIDGE CAPITAL MANAGEMENT LLC

Position in CERO — Cero Therapeutics Holdings, Inc.

CIK 919185 NEW YORK, NY

Position in CERO

as of Dec 31, 2024 · filed Feb 12, 2025 Compact

Position Value

+$0 QoQ

Shares Held

270,552

-67.4% QoQ

Ownership

0.378%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

HIGHBRIDGE CAPITAL MANAGEMENT LLC holds $22,154,220 across 5 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	155,857	$20,686,899
2	SLS	SELLAS Life Sciences Group, Inc.	99,400	$1,467,144
3	CLDI	Calidi Biotherapeutics, Inc.	65	$177
4	OSRH	OSR Health, Inc.	106,730	$0
5	ASBP	Aspire Biopharma Holdings, Inc.	94,792	$0

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2024-12-31 CEROW	—	270,552	-67.4%	Principal	Sole	2025-02-12
2024-09-30 CEROW	—	829,598	0.0%	Principal	Sole	2024-11-08
2024-06-30 CEROW	—	829,598	+0.1%	Principal	Sole	2024-08-12
2024-03-31 CEROW	—	828,544	+79.9%	Principal	Sole	2024-05-10
2023-12-31 CEROW	—	460,652	-35.6%	Principal	Sole	2024-02-12
2023-09-30 CEROW	—	714,827	0.0%	Principal	Sole	2023-11-13
2023-06-30 CEROW	—	714,827	+23.7%	Principal	Sole	2023-08-11
2023-03-31 CEROW	—	577,844	+16.7%	Principal	Sole	2023-08-14
2022-12-31 CEROW	—	495,194	-26.4%	Principal	Sole	2023-02-13
2022-09-30 CEROW	—	672,608	-0.7%	Principal	Sole	2022-11-14
2022-09-30	$11,023,617	1,092,529	+6.1%	Shares	Sole	2022-11-14
2022-06-30 CEROW	—	677,408	+60.5%	Principal	Sole	2022-08-11
2022-06-30	$10,313,205	1,029,262	-0.5%	Shares	Sole	2022-08-11
2022-03-31 CEROW	—	422,033	-6.2%	Principal	Sole	2022-05-11
2022-03-31	$10,323,990	1,033,950	-0.4%	Shares	Sole	2022-05-11
2021-12-31 CEROW	—	449,696	—	Principal	Sole	2022-02-11
2021-12-31	$10,284,538	1,037,794	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.